Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1603869 | 0.81 | L3MBTL1 (0.56) | L3MBTL1CYP1A2POLBLMNAADORA3 | |
| SCHEMBL2491687 | 0.78 | LMNA (0.63) | L3MBTL1CYP1A2POLBHTTLMNA | |
| SCHEMBL2472029 | 0.78 | EPHX2 (0.44) | L3MBTL1EPHX2HTTLMNAGAA | |
| SCHEMBL3368297 | 0.77 | EPHX2 (0.41) | EPHX2HTTLMNAHSD17B10GAA | |
| SCHEMBL513746 | 0.76 | EPHX2 (0.43) | CYP1A2EPHX2HTTLMNAGAA | |
| SCHEMBL9948617 | 0.76 | LMNA (0.46) | EPHX2POLBHTTLMNAADORA3 | |
| SCHEMBL14069596 | 0.74 | LMNA (0.45) | L3MBTL1CYP1A2POLBHTTLMNA | |
| SCHEMBL13304496 | 0.74 | ADORA3 (0.46) | L3MBTL1CYP1A2POLBHTTLMNA | |
| SCHEMBL6172380 | 0.74 | L3MBTL1 (0.43) | L3MBTL1CYP1A2POLBHTTLMNA | |
| SCHEMBL15942897 | 0.74 | L3MBTL1 (0.48) | L3MBTL1CYP1A2POLBHTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9873811-B2 | Highly conductive material formed by hybridization of metal nanomaterial and carbon nanomaterial having higher-order structure due to multiple hydrogen bonding, and manufacturing method therefor | KOREA ELECTROTECHNOLOGY RESEARCH INSTITUTE (KR) | 2018-01-23 | — | — | US | claimed |
| US-20160009934-A1 | HIGHLY CONDUCTIVE MATERIAL FORMED BY HYBRIDIZATION OF METAL NANOMATERIAL AND CARBON NANOMATERIAL HAVING HIGHER-ORDER STRUCTURE DUE TO MULTIPLE HYDROGEN BONDING, AND MANUFACTURING METHOD THEREFOR | KOREA ELECTROTECHNOLOGY RESEARCH INSTITUTE | 2016-01-14 | — | — | US | claimed |
| US-9227941-B2 | Carbon nanomaterial having higher order structure by means of multiple hydrogen bonds and method for preparing same | Korea Eletrotechnology Research Institute (KR) | 2016-01-05 | — | — | US | claimed |
| US-20150218108-A1 | CARBON NANOMATERIAL HAVING HIGHER ORDER STRUCTURE BY MEANS OF MULTIPLE HYDROGEN BONDS AND METHOD FOR PREPARING SAME | KOREA ELECTROTECHNOLOGY RESEARCH INSTITUTE (KR) | 2015-08-06 | — | — | US | claimed |
| US-9873811-B2 | Highly conductive material formed by hybridization of metal nanomaterial and carbon nanomaterial having higher-order structure due to multiple hydrogen bonding, and manufacturing method therefor | KOREA ELECTROTECHNOLOGY RESEARCH INSTITUTE (KR) | 2018-01-23 | — | — | US | disclosed |
| US-20160009934-A1 | HIGHLY CONDUCTIVE MATERIAL FORMED BY HYBRIDIZATION OF METAL NANOMATERIAL AND CARBON NANOMATERIAL HAVING HIGHER-ORDER STRUCTURE DUE TO MULTIPLE HYDROGEN BONDING, AND MANUFACTURING METHOD THEREFOR | KOREA ELECTROTECHNOLOGY RESEARCH INSTITUTE | 2016-01-14 | — | — | US | disclosed |
| US-9227941-B2 | Carbon nanomaterial having higher order structure by means of multiple hydrogen bonds and method for preparing same | Korea Eletrotechnology Research Institute (KR) | 2016-01-05 | — | — | US | disclosed |
| US-20150218108-A1 | CARBON NANOMATERIAL HAVING HIGHER ORDER STRUCTURE BY MEANS OF MULTIPLE HYDROGEN BONDS AND METHOD FOR PREPARING SAME | KOREA ELECTROTECHNOLOGY RESEARCH INSTITUTE (KR) | 2015-08-06 | — | — | US | disclosed |
| US-20120165334-A1 | Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors | AMGEN INC. (US) | 2012-06-28 | — | — | US | disclosed |
| CN-101712222-A | Protective article and methods of manufacture thereof | GEN ELECTRIC | 2010-05-26 | — | — | CN | disclosed |
| CN-88100822-A | Be used as 2,6 one substituted pyridine compound and herbicidal methods thereof of the replacement of weedicide | — | 1988-09-14 | — | — | CN | disclosed |
| US-4340419-A | S-triazine herbicidal antidotes | STAUFFER CHEMICAL COMPANY (US) | 1982-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165334-A1 | Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors | MTOR, PIKFYVE, RICTOR | L3MBTL1 2849/4885CYP1A2 2418/4885EPHX2 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.